Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease

Table 2 Univariate analyses of factors associated with cardiovascular disease among 1221 subjects

	Odds ratio (95% CI)	P
NAFLD	5.37 (2.29-12.58)	< 0.001
Gamma -glutamyltransferase, U/L	1.02 (1.01-1.03)	< 0.001
Age, 10 yr	2.30 (1.46-3.61)	< 0.001
Men	1.70 (0.66-4.38)	0.27
The Brinkman index, 100 index1	1.08 (1.00-1.17)	0.049
LDL-C, mmol/L	1.48 (0.89-2.46)	0.13
The metabolic syndrome	3.14 (1.26-7.83)	0.014
The components of metabolic syndrome
BMI, kg/m2	1.14 (1.00-1.31)	0.044
Fasting plasma glucose, mmol/L	1.42 (1.01-2.01)	0.046
Systolic blood pressure, 10 mmHg	1.72 (1.4-2.12)	< 0.001
Diastolic blood pressure, 10 mmHg	2.31 (1.57-3.39)	< 0.001
HDL-C, mmol/L	0.16 (0.03-0.84)	0.031
Triglycerides, mmol/L	1.61 (1.11-2.32)	0.012

NAFLD: nonalcoholic fatty liver disease; LDL-C: low dense lipoprotein cholesterol; HDL-C: high dense lipoprotein cholesterol.

¹The Brinkman index is the number of cigarettes per day multiplied by years of smoking. A higher value indicates increased smoking-associated health hazard.